ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BNR Burning Rock Biotech Ltd

0.35
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Burning Rock Biotech Ltd LSE:BNR London Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 0.35 0 01:00:00

Blenheim Natural Resources PLC Conditional Placing to raise £750,000 (4112U)

18/01/2017 7:05am

UK Regulatory


Burning Rock Biotech (LSE:BNR)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Burning Rock Biotech Charts.

TIDMBNR

RNS Number : 4112U

Blenheim Natural Resources PLC

18 January 2017

18 January 2017

Blenheim Natural Resources Plc

("Blenheim" or the "Company")

Oversubscribed Conditional Placing to Raise GBP750,000

The Company is pleased to announce that it has raised a total of GBP750,000 before expenses through a placing of 214,285,714 ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") at a price of 0.35 pence per share per Ordinary Share (the "Placing"), subject to shareholder approval.

The net proceeds of the placing will be used by the Company to make further investments in accordance with its investing policy, including to fund the cash consideration, should the Company exercise its the option to acquire a 30 per cent interest in the Dieba exploration permit in Southern Mali, as set out in the Company's RNS dated 18 January 2017. The net proceeds of the Placing will also be used to provide Blenheim with general working capital.

The Company has agreed to grant warrants over Ordinary Shares to subscribers on the basis of one warrant for every Ordinary Share taken up under the Placing, each entitling the holder to subscribe for a further Ordinary Share at a price of 0.65 pence per Ordinary Share (the "Placing Warrants"), exercisable at any time for a period of two years from the date of admission of the Placing Shares to trading on the AIM Market of the London Stock Exchange.

In connection with the Placing, the Company has also agreed to issue 10,714,286 warrants, each entitling the holder to subscribe for a further Ordinary Share at an exercise price of 0.35 pence per Ordinary Share, to Cornhill Capital Limited, the Company's joint broker (the "Broker Warrants"). The Broker Warrants will be exercisable at any time for a period of three years from the date of issue of Ordinary Shares pursuant to the Placing.

The Placing, which was oversubscribed, is conditional on and subject to the passing of the relevant shareholder resolutions at a general meeting of the Company. The Company will shortly convene a general meeting to, inter alia, grant the directors the authorities to issue and allot 214,285,714 Ordinary Shares and 214,285,714 Placing Warrants pursuant to the Placing, and the 10,714,286 Broker Warrants. A notice of General Meeting will shortly be sent to shareholders and further announcements will be made as soon as practicable.

Ends

For further information please contact:

 
                                Blenheim Natural       +44 (0) 1622 
Chris Ells                       Resources Plc          844601 
 
Colin Aaronson/Jamie Barklem/   Grant Thornton UK      +44 (0) 20 
 Daniel Bush                     LLP                    7383 5100 
 
                                                       +44 (0)1483 
Nick Emerson                    SI Capital Ltd          413500 
                                Peterhouse Corporate   +44 (0) 20 
Lucy Williams / Duncan Vasey     Finance Limited        7469 0932 
                                Cornhill Capital       +44 (0) 20 
Colin Rowbury                    Limited                7710 9610 
 

The information contained within this announcement is considered to be inside information, for the purposes of Article 7 of EU Regulation 596/2014, prior to its release.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEMMGMMGNDGNZZ

(END) Dow Jones Newswires

January 18, 2017 02:05 ET (07:05 GMT)

1 Year Burning Rock Biotech Chart

1 Year Burning Rock Biotech Chart

1 Month Burning Rock Biotech Chart

1 Month Burning Rock Biotech Chart

Your Recent History

Delayed Upgrade Clock